5 healthcare vendors recognized for AI innovation

The market intelligence outfit International Data Corp. has named five suppliers of healthcare software to its IDC Innovators list.

What the five have in common are products aimed at helping providers improve patient engagement by leveraging AI, according to an announcement. The recognized companies also meet IDC’s criteria for having revenues below $100 million.

Here they are, along with IDC’s summary of their respective selection-earning achievements:

  • Cogitativo combines healthcare data with machine learning algorithms to identify problems, uncover insights and make recommendations on process changes that are based on Cogitativo’s intellectual property combined with the client’s unique situation.

 

  • Integra Connect offers a specialty care platform that cleanses and normalizes data from providers and payers, subjects it to analytics that identify patients at risk, monitors clinical and financial performance, and delivers insights that optimize patient care and quality.

 

  • Jvion uses computational capabilities, an AI asset containing patient, socioeconomic, and third-party data, and machine learning algorithms to address patient outcomes across a wide range of clinical conditions and make recommendations of next best action.
  • LifeLink provides a platform for chatbot solutions that enables clients to address complex workflows and uses conversational AI to help patients navigate the healthcare experience, resulting in better engagement in their care.

 

  • Medial EarlySign combines laboratory, clinical, and electronic medical record data with computational rigor to detect patients that are at risk or in the early stage of a high-burden illness, allowing clinicians to intervene at the earliest opportunity.

IDC says the vendors profiled in its series of reports on innovators are picked by an analyst with expertise in a given market space. Recognized companies “offer an innovative new technology, a groundbreaking approach to an existing issue and/or an interesting new business model. It is not an exhaustive evaluation of all companies in a segment or a comparative ranking of the companies.”

IDC is offering the full report on patient-engagement achievers for $2,500.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.